๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adrenal suppression by megestrol-(MA) or medroxyprogesterone acetate (MPA) in advanced breast cancer

โœ Scribed by P.H.B. Willemse; D.Th. Sleijfer; N.H. Mulder; E.G.E. de Vries; L.D. Dikkeschei; B.C. Wolthers; T. Tjabbes; H. van Veelen

Book ID
116006756
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
123 KB
Volume
28
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adrenal suppression by oral high-dose me
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients
โœ Henk Veelen; Pax H. B. Willemse; Dirk T. Sleijfer; John J. Pratt; Wim J. Sluiter ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 332 KB

The effects of oral MPA, 300 mg t.i.d., on adrenal function in postmenopausal patients with disseminated breast cancer were evaluated. The levels of serum cortisol, ACTH, androstenedione, DHEA-S, LH, FSH, GH, and prolactin in 22 patients receiving MPA were compared with those in another group of 28

Mechanism of adrenal suppression by high
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients
โœ H. Veelen; P. H. B. Willemse; D. T. Sleijfer; E. Ploeg; W. J. Sluiter; H. Dooren ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 362 KB

To investigate the mechanism of adrenal suppression by high-dose MPA, we performed direct and indirect stimulation tests in postmenopausal women with disseminated breast cancer who were receiving MPA and in a postmenopausal breast cancer control group. A partial adrenal insufficiency was found durin